Literature DB >> 16702229

Outlier sums for differential gene expression analysis.

Robert Tibshirani1, Trevor Hastie.   

Abstract

We propose a method for detecting genes that, in a disease group, exhibit unusually high gene expression in some but not all samples. This can be particularly useful in cancer studies, where mutations that can amplify or turn off gene expression often occur in only a minority of samples. In real and simulated examples, the new method often exhibits lower false discovery rates than simple t-statistic thresholding. We also compare our approach to the recent cancer profile outlier analysis proposal of Tomlins and others (2005).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16702229     DOI: 10.1093/biostatistics/kxl005

Source DB:  PubMed          Journal:  Biostatistics        ISSN: 1465-4644            Impact factor:   5.899


  64 in total

1.  Multi-level mixed effects models for bead arrays.

Authors:  Ryung S Kim; Juan Lin
Journal:  Bioinformatics       Date:  2010-12-17       Impact factor: 6.937

2.  Robust identification of transcriptional regulatory networks using a Gibbs sampler on outlier sum statistic.

Authors:  Jinghua Gu; Jianhua Xuan; Rebecca B Riggins; Li Chen; Yue Wang; Robert Clarke
Journal:  Bioinformatics       Date:  2012-05-17       Impact factor: 6.937

3.  The identification of auto-antibodies in pancreatic cancer patient sera using a naturally fractionated Panc-1 cell line.

Authors:  Chen Li; Hye-Yeung Kim; Huy Vuong; Tasneem Patwa; Manoj Pal; Randall E Brand; Diane M Simeone; David M Lubman
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

4.  Predicting gene targets of perturbations via network-based filtering of mRNA expression compendia.

Authors:  Elissa J Cosgrove; Yingchun Zhou; Timothy S Gardner; Eric D Kolaczyk
Journal:  Bioinformatics       Date:  2008-09-08       Impact factor: 6.937

5.  The distribution-based p-value for the outlier sum in differential gene expression analysis.

Authors:  Lin-An Chen; Dung-Tsa Chen; Wenyaw Chan
Journal:  Biometrika       Date:  2010-01-25       Impact factor: 2.445

6.  Precision Oncology beyond Targeted Therapy: Combining Omics Data with Machine Learning Matches the Majority of Cancer Cells to Effective Therapeutics.

Authors:  Michael Q Ding; Lujia Chen; Gregory F Cooper; Jonathan D Young; Xinghua Lu
Journal:  Mol Cancer Res       Date:  2017-11-13       Impact factor: 5.852

7.  Identification of novel microRNA regulatory pathways associated with heterogeneous prostate cancer.

Authors:  Yifei Tang; Wenying Yan; Jiajia Chen; Cheng Luo; Antti Kaipia; Bairong Shen
Journal:  BMC Syst Biol       Date:  2013-10-16

Review 8.  Recurrent gene fusions in prostate cancer.

Authors:  Chandan Kumar-Sinha; Scott A Tomlins; Arul M Chinnaiyan
Journal:  Nat Rev Cancer       Date:  2008-06-19       Impact factor: 60.716

9.  Comparison of scores for bimodality of gene expression distributions and genome-wide evaluation of the prognostic relevance of high-scoring genes.

Authors:  Birte Hellwig; Jan G Hengstler; Marcus Schmidt; Mathias C Gehrmann; Wiebke Schormann; Jörg Rahnenführer
Journal:  BMC Bioinformatics       Date:  2010-05-25       Impact factor: 3.169

10.  LSOSS: Detection of Cancer Outlier Differential Gene Expression.

Authors:  Yupeng Wang; Romdhane Rekaya
Journal:  Biomark Insights       Date:  2010-08-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.